Vernalis receives $2m milestone as part of research collaboration
Shares in Vernalis tumbled on Friday despite the drug developer announcing it had received a $2m milestone under one of its existing research collaborations.
FTSE AIM 100
3,637.40
17:14 26/04/24
n/a
n/a
FTSE AIM All-Share
755.28
17:14 26/04/24
n/a
n/a
Pharmaceuticals & Biotechnology
22,773.26
16:59 26/04/24
0.10%
22.78
Vernalis plc
6.17p
12:19 09/10/18
0.00%
0.00p
The collaboration was to discover novel small molecules against an undisclosed target using Vernalis' fragment and structure-based drug discovery platform.
Chief executive Ian Garland said: "We are delighted to receive this payment which recognises the success of our research group's work."
Shares in Vernalis were down 13.71% to 21.25p at 0915 BST.